

Background: Unfavorable lipid profile presents one of most important risk factor for cardiovascular disease in renal pathology. Myeloperoxidase (MPO) as enzyme which oxidizes lipoproteins and paraoxonase1 (PON1) as anti-oxidative enzyme have been involved in pathogenesis of cardiovascular disease. In the present study we sought to assess oxidative stress status, lipoprotein subclasses distribution as well as functionality of high density lipoprotein (HDL) trough MPO/PON1 ratio in children with chronic kidney disease (CKD) and children after renal transplantation. Methods: PON1 activity and oxidative stress parameters were measured spectrophotometrically, while MPO concentration was determined using immunoassay. Separation of lipoprotein subclasses was performed by vertical gradient gel electrophoresis in 19 children with different stage of CKD and 19 post-transplantation patients (PT). Results: CKD patients had increased MPO/PON1 ratio and higher prevalence of smaller HDL subclasses when compared to PT subjects. Also, there was a significant positive correlation between MPO level and MPO/PON1 ratio with relative proportion of smaller HDL subclasses. Conclusion: Children with CKD have impaired HDL distribution that is improved after kidney transplantation. Since that measurement of HDL distribution and functionality are not routinely available, MPO/PON1 ratio may be useful marker that could provide necessary information. © by Aleksandra Stefanović 2017.
| EMTREE drug terms: | adiponectinadvanced oxidation protein productapolipoprotein A1apolipoprotein B100aryldialkylphosphatase 1high density lipoproteinhigh density lipoprotein cholesterolleptinlow density lipoprotein cholesterolmyeloperoxidasethiobarbituric acid reactive substancetriacylglycerol |
|---|---|
| EMTREE medical terms: | adolescentadultArticlechildcholesterol blood levelclinical articlecontrolled studyelectrophoretic mobilityend stage renal diseasefemalegel electrophoresishumankidney transplantationmaleoxidative stressparticle sizewaist hip ratio |
adiponectin, 283182-39-8; myeloperoxidase
| Funding sponsor | Funding number | Acronym |
|---|---|---|
| Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja | 175035 | MPNTR |
Research funding: This work is supported by
Stefanović, A.; Department of Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia;
© Copyright 2017 Elsevier B.V., All rights reserved.